Dr. Reddy’s and GRA Announce Clinically Meaningful Data from Avigan Pivotal Studies
Sub-group analysis shows three-day earlier discharge from hospital in low-risk patients hospitalized with COVID-19 Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) and Global Response Aid FZCO (GRA) today announced results from an Avigan study on moderate-severe hospitalized COVID-19 patients in […]
